Related Experiment Video
Updated: May 29, 2026
08:23
Single Droplet Digital Polymerase Chain Reaction for Comprehensive and Simultaneous Detection of Mutations in Hotspot Regions
Published on: September 25, 2018
[Tm analysis method using a quenching probe is a simple and rapid way to simultaneously detect KRAS and BRAF
1Division of Molecular Diagnosis and Cancer Prevention, Saitama Cancer Center, Kitaadachi-gun, Saitama-pref. 362-0806, Japan. Akagi@cancer-c.pref.saitama.jp
Rinsho Byori. the Japanese Journal of Clinical Pathology
|September 28, 2011
Summary
Detecting KRAS and BRAF mutations is key to predicting resistance to epidermal growth factor receptor (EGFR)-targeted therapies. A novel Tm analysis method allows for the simultaneous detection of these mutations, aiding clinical decisions.
Area of Science:
- Oncology
- Molecular Biology
- Genetics
Background:
- Epidermal growth factor receptor (EGFR) signaling pathways are crucial for cell proliferation.
- EGFR-targeted therapies offer clinical benefits but face resistance.
- Mutations in KRAS and BRAF predict resistance to EGFR-targeted drugs, particularly in colorectal cancer.
Purpose of the Study:
- To develop a method for simultaneous detection of KRAS and BRAF mutations.
- To identify predictive markers for resistance to EGFR-targeted therapies.
Main Methods:
- Utilized Tm analysis with a quenching probe for simultaneous KRAS and BRAF mutation detection.
- Oligonucleotide probes with 5'-end fluorescent dyes interact with guanine for quenching.
- Differential probe dissociation temperatures at varying heat identify mutations.
Main Results:
- A simple and rapid method for simultaneous KRAS and BRAF mutation detection was established.
- The method relies on fluorescence changes upon probe dissociation at specific temperatures.
- This technique aids in predicting resistance to EGFR-targeted therapies.
Conclusions:
- Simultaneous detection of KRAS and BRAF mutations is important for predicting resistance to EGFR-targeted therapies.
- The developed Tm analysis method is a valuable tool for clinical practice.
- This approach can guide treatment decisions in oncology.
